WAY · NASDAQ · Medical - Healthcare Information Services

Waystar (WAY)

Automates healthcare reimbursement, patient payments, denial recovery, and clinical revenue workflows.

$25.57
vs last close−0.14 (−0.54%)
Loading prices…

Waystar Holding Corp.WAY
Health Care

Provides cloud software for financial clearance, patient collections, claims, denials, clinical integrity, revenue capture, and analytics across U.S. healthcare providers. Revenue comes primarily from recurring subscription and volume-based fees, while the unified platform depends on integrations with provider, payer, and payment networks.

Provides cloud software that manages healthcare payments for U.S. hospitals, health systems, physician practices, clinics, laboratories, and other care providers. The platform spans financial clearance and prior authorization, patient financial care, claims and payer payment management, denial prevention and recovery, clinical integrity and revenue capture, and analytics and reporting. AltitudeAI applies automation across these workflows, including claim checking, appeal preparation, documentation review, and missing-charge detection.

Earns primarily recurring subscription and volume-based fees, with transaction activity rising as clients serve more patients or add solutions and care sites. A unified, multi-tenant platform connects with EHR, practice-management, and payer systems and processes regulated clinical, claims, and payment data. Execution depends on reliable integrations, secure data handling, card-network and ACH rules, payer requirements, and changing healthcare and privacy regulation.

Company facts

CEOMatthew J. Hawkins
ListedJun 7, 2024
ExchangeNASDAQ
HeadquartersLehi, UT
CountryUnited States
Employees1,700
CIK0001990354
ISINUS9467841055

Market cap$4.93B
EPS (ttm)$0.7000
P/E (ttm)36.73
ROE3.6%
P/B1.24
P/S4.09
Dividend yieldDiv yield
Beta0.59vs XLV 0.62

Price target$33.00+28.4%Average of 17 analysts
ConsensusBuy16 of 17 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Sep 16, 2026Morgan StanleyReiterate
Rating: Target:
Rating: Equal-WeightTarget: $28
Sep 15, 2026BarclaysDowngrade
Rating: OverweightTarget: $27
Rating: Equal WeightTarget: $30
Aug 31, 2026Canaccord GenuityReiterate
Rating: Target: $30
Rating: BuyTarget: $33
Aug 13, 2026Truist FinancialTarget
Target: $38
Target: $33
Aug 13, 2026Wolfe ResearchUpgrade
Rating:
Rating: Outperform

Next report
Nov 4, 26
in 43 days
EPS estimate
$0.41
Revenue estimate
$323.3M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Nov '26
Reported$0.29$0.32$0.36$0.37$0.36$0.42$0.43Pending
Estimate$0.15$0.32$0.33$0.34$0.39$0.39$0.40$0.41
Surprise+93.3%0.0%+9.1%+8.8%−7.7%+7.7%+8.0%

RevenueReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Nov '26
Reported$244.1M$256.4M$270.7M$268.7M$303.5M$313.9M$319.7MPending
Estimate$248.5M$254.0M$256.1M$294.7M$294.8M$311.7M$316.2M$323.3M
Surprise−1.8%+1.0%+5.7%−8.8%+3.0%+0.7%+1.1%
Estimate$0.41
ReportedDue Nov 4, 2026
Estimate$323.3M
ReportedDue Nov 4, 2026
View details

Debt to equity37.20%
Current ratio184.70%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$240.1M$244.1M$256.4M$270.7M$268.7M$303.5M$313.9M$319.7M
Net income$5.4M$19.1M$29.3M$32.2M$30.6M$20.0M$43.3M$40.9M
Net margin2.3%7.8%11.4%11.9%11.4%6.6%13.8%12.8%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$27.1M$53.1M$65.2M$64.8M$60.2M$59.0M$80.5M$76.0M
YoY growth−15.7%+41.0%+85.3%+686.5%+121.9%+11.1%+23.4%+17.3%

Balance sheet, Jun 30, 2026Cash & short-term investments $191.6M · Total debt $1.48B · Total assets $5.87B · Shareholders' equity $3.99B

Revenue
$319.7M
Operating income
$76.0M
Net income
$40.9M
View details

No dividends on record.

Institutions111.06%212.96M shares
319 holders · as of Jun 30, 2026
Insiders2.20%4.21M shares
17 holders · as of Sep 8, 2026
Strategic holders12.48%23.94M shares
1 holder · as of Dec 16, 2024
Adds to125.74%

191.75M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 125.74%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Eqt Fund Management S.A R.L.Institution
12.98%24.88Mas of Jun 30, 2026
BCPE Derby (DE) SPV, LPStrategic10 percent owner
12.48%23.94Mfiled Dec 16, 2024
Canada Pension Plan Investment BoardInstitution
9.92%19.03Mas of Jun 30, 2026
BlackRock, Inc.Institution
9.09%17.44Mas of Jun 30, 2026
FMR LLCInstitution
7.85%15.05Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 2, 2026Matthew J. Hawkinsdirector, officer: Chief Executive Officer−82,500$25.97
Aug 13, 2026Matthew J. Hawkinsdirector, officer: Chief Executive Officer−60,038$25.01
Aug 11, 2026Matthew J. Hawkinsdirector, officer: Chief Executive Officer−22,462$25.04
Jul 15, 2026Matthew J. Hawkinsdirector, officer: Chief Executive Officer−33,099$23.02
Jul 16, 2026Matthew J. Hawkinsdirector, officer: Chief Executive Officer−36,901$23.09
View details

  • UnitedHealth Group

    Broad RCM and claims network through Optum / Change Healthcare

  • Oracle

    EHR-native patient accounting and RCM automation

  • Flywire

    Patient financial engagement and healthcare payments

  • HealthEquity

    Consumer healthcare payment accounts and processing

Compare

CompanyPriceChange
Waystar$25.57−0.54%$4.93B36.714.74.1+18.1%
UnitedHealth Group$373.93−0.96%$342.88B24.317.50.8+0.4%
Oracle$149.85+0.87%$427.95B23.317.66.0+29.6%
Flywire$17.38+1.47%$2.08B66.423.12.9+24.2%
HealthEquity$92.64−1.99%$7.90B34.118.35.8+7.6%
Median29.218.04.4+15.9%